Astellas Patient Assistance Program
The Astellas Patient Assistance Program provides Prograf® (tacrolimus) at no cost to patients who meet the program eligibility requirements.
Prograf Support Solutionsa can assess whether the patient meets the eligibility requirements.
The patient may be eligible if they meet the following criteria:
- Be uninsured or have insurance that excludes coverage for Prografb
- Have a verifiable shipping address in the United States
- Have been prescribed Prograf for an FDA-approved indication
- Meet income eligibility criteria
a Prograf Support Solutions is a component of Astellas Pharma Support SolutionsSM.
b Other insured patients may be eligible for the program if they meet certain eligibility criteria.